Influence of fenofibrate treatment on triacylglycerides, diacylglycerides and fatty acids in fructose fed rats.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractFenofibrate (FF) lowers plasma triglycerides via PPARα activation. Here, we analyzed lipidomic changes upon FF treatment of fructose fed rats. Three groups with 6 animals each were defined as control, fructose-fed and fructose-fed/FF treated. Male Wistar Unilever Rats were subjected to 10% fructose-feeding for 20 days. On day 14, fenofibrate treatment (100 mg/kg p.o.) was initiated and maintained for 7 days. Lipid species in serum were analyzed using mass spectrometry (ESI-MS/MS; LC-FT-MS, GC-MS) on days 0, 14 and 20 in all three groups. In addition, lipid levels in liver and intestine were determined. Short-chain TAGs increased in serum and liver upon fructose-feeding, while almost all TAG-species decreased under FF treatment. Long-chain unsaturated DAG-levels (36:1, 36:2, 36:4, 38:3, 38:4, 38:5) increased upon FF treatment in rat liver and decreased in rat serum. FAs, especially short-chain FAs (12:0, 14:0, 16:0) increased during fructose-challenge. VLDL secretion increased upon fructose-feeding and together with FA-levels decreased to control levels during FF treatment. Fructose challenge of de novo fatty acid synthesis through fatty acid synthase (FAS) may enhance the release of FAs ≤ 16:0 chain length, a process reversed by FF-mediated PPARα-activation.
CitationInfluence of fenofibrate treatment on triacylglycerides, diacylglycerides and fatty acids in fructose fed rats. 2014, 9 (9):e106849 PLoS ONE
The following license files are associated with this item:
- Chronic exercise provides renal-protective effects with upregulation of fatty acid oxidation in the kidney of high fructose-fed rats.
- Authors: Hu G, Xu L, Ma Y, Kohzuki M, Ito O
- Issue date: 2020 Mar 1
- Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression.
- Authors: Abd El-Haleim EA, Bahgat AK, Saleh S
- Issue date: 2016 Mar 14
- Dietary oligofructose modifies the impact of fructose on hepatic triacylglycerol metabolism.
- Authors: Kok N, Roberfroid M, Delzenne N
- Issue date: 1996 Dec
- Amelioration of high fructose-induced metabolic derangements by activation of PPARalpha.
- Authors: Nagai Y, Nishio Y, Nakamura T, Maegawa H, Kikkawa R, Kashiwagi A
- Issue date: 2002 May
- Altered hepatic metabolism of fatty acids in rats fed a hypolipidaemic drug, fenofibrate.
- Authors: Yamamoto K, Fukuda N, Zhang L, Sakai T
- Issue date: 1996 Jun